Nine-Hole Peg Test

(redirected from 9-HPT)

Nine-Hole Peg Test

,

9-HPT

A timed performance test in which a subject places nine dowels in nine holes and then removes them, first with the dominant hand and then with the nondominant one. The more rapidly the test is performed, the greater the dexterity of the subject.
References in periodicals archive ?
Background: The 9-hole peg test (9-HPT) and 10-meter walk test (10-MWT) are commonly used to test finger motor function and walking ability.
All control subjects were assessed using 9-HPT and 10-MWT, and all patients underwent a standardized protocol that included the following evaluations:
The dominant hand completed 9-HPT faster than the nondominant hand (CMT group: t = −2.060, P = 0.047; control group: t = −5.464, P < 0.001).
There was a positive correlation of 9-HPT completion time with ONLS and FDS, and a negative correlated with BBS just for CMT patients.
The was a positive correlation of the course of disease with CMTES ( r = 0.491, P = 0.003), but no correlation with 9-HPT completion time (dominant hand: r = 0.009, P = 0.960; nondominant hand: r = −0.023, P = 0.897), ASSV ( r = −0.061, P = 0.746), AFV ( r = −0.156, P = 0.402), ONLS ( r = 0.175, P = 0.323), FDS ( r = −0.028, P = 0.875), and BBS ( r = −0.182, P = 0.
Further, reduced thumb mobility and intrinsic finger function in CMT patients limited prehension, resulting in abnormal posture during the 9-HPT test.
The 9-HPT is a standardized, ratio scale tool with established norms, and is available and portable for use in a variety of settings, including the clinic, laboratory, and home.
Timed 25-FootWalk (25FTW), 9-Hole Peg Test (9-HPT), and Paced Auditory Serial Addition Task-3 (PASAT-3) were completed in the MS cases as part of the Multiple Sclerosis Functional Composite (MSFC) assessment.
Slower 9-HPT times were also correlated with lower fornix FA and MTR and higher fornix MD, [[lambda].sub.II], and [[lambda].sub.[perpendicular to]].
Slower 9-HPT times were correlated with lower FA and higher MD and [[lambda].sub.[perpendicular to]].
of participants 101 64 Age, year, 44 [+ or -] 12 39 [+ or -] 11 mean [+ or -] SD Women , (%) 75 (74%) 41 (64%) Disease duration, years, 11.5 [+ or -] 10.2 7.1 [+ or -] 6.3 mean [+ or -] SD Median EDSS (range) 3 (0-8) 2 (0-6.5) 25FTW, sec, median 4.7 (4.2-35.0) 4.5 (3.9-12.4) (interquartile range) 9-HPT, sec, median 24 (20-28) 21 (19-25) (interquartile range) PASAT-3, median score 51 (38-60) 51 (40-60) (interquartile range) SPMS PPMS No.